RECORD // Company

Enanta Pharmaceuticals Inc

Built 2026-11-22T00:37:17Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Enanta Pharmaceuticals, Inc · Ctgov · same registered legal name as 'ENANTA PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • ENANTA PHARMACEUTICALS INC · Epa echo · same registered legal name as 'ENANTA PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-K · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-K for the period ended 2026-09-30, filed 2026-11-18 · accession 0001193125-26-466170

ItemValuePeriodFormFiledAccessionReport
Revenue$63,001,00012 months ended 2026-09-3010-K2026-11-180001193125-26-4661702026-11-22 00:37 UTCReport an error
Net income (loss)$-68,248,00012 months ended 2026-09-3010-K2026-11-180001193125-26-4661702026-11-22 00:37 UTCReport an error
Interest expense$14,074,00012 months ended 2026-09-3010-K2026-11-180001193125-26-4661702026-11-22 00:37 UTCReport an error
Cash and cash equivalents$20,272,000at 2026-09-3010-K2026-11-180001193125-26-4661702026-11-22 00:37 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001177648
Ticker
ENTA
EIN
043205099
CUSIP
29251M106
Record ID
sx:sec:0001177648

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

35 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-22 00:37 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-18SEC EDGAR company profile2026-11-22 00:37 UTCReport an error
Fiscal year end (MMDD)09302026-11-18SEC EDGAR company profile2026-11-22 00:37 UTCReport an error
Business address4 KINGSBURY AVENUE, WATERTOWN, MA, 024722026-11-18SEC EDGAR company profile2026-11-22 00:37 UTCReport an error
ExchangesNasdaq2026-11-18SEC EDGAR company profile2026-11-22 00:37 UTCReport an error
Revenue (fiscal year ended 2026-09-30)$63,001,0002026-09-3010-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 00:37 UTCReport an error
Net income (loss) (fiscal year ended 2026-09-30)$-68,248,0002026-09-3010-K, XBRL NetIncomeLoss2026-11-22 00:37 UTCReport an error
Total assets (at 2026-09-30)$275,577,0002026-09-3010-K, XBRL Assets2026-11-22 00:37 UTCReport an error
Stockholders' equity (at 2026-09-30)$80,195,0002026-09-3010-K, XBRL StockholdersEquity2026-11-22 00:37 UTCReport an error
Cash and cash equivalents (at 2026-09-30)$20,272,0002026-09-3010-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:37 UTCReport an error
Operating cash flow (fiscal year ended 2026-09-30)$-42,560,0002026-09-3010-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:37 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2026-09-30)$206,0002026-09-3010-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:37 UTCReport an error
Operating lease liabilities (at 2026-09-30)$54,757,0002026-09-3010-K, XBRL OperatingLeaseLiability2026-11-22 00:37 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-16)On November 16, 2026, Enanta Pharmaceuticals, Inc. announced via press release its results for the fiscal quarter and year ended September 30, 2026. A copy of Enanta's press release is hereby furnished to the Commission and incorporated by reference herein as Exhibit 99.1.2026-11-16SEC EDGAR 8-K 0001193125-26-463508 (text as filed, excerpt)2026-11-22 00:37 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-10-29)As previously disclosed, Enanta Pharmaceuticals, Inc. (the “Company”) filed a patent infringement action in the Unified Patent Court (the “UPC”) of the European Union against Pfizer Inc. and certain of its subsidiaries, seeking a determination of liability for infringement of European Patent No. EP 4 051 265 (the “‘265 Patent”) in connection with Pfizer’s manufacture, use, and sale of Paxlovid™ (nirmatrelvir tablets; ritonavir tablets) in the 18 EU member states participating in the UPC. Pfizer counterclaimed for revocation of the ’265 Patent. A hearing on the infringement action and counterclaim for revocation was held on September 29, 2026. On October 29, 2026, the UPC released its…2026-10-29SEC EDGAR 8-K 0001193125-26-437774 (text as filed, excerpt)2026-11-22 00:37 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-10)On August 10, 2026, Enanta Pharmaceuticals, Inc. announced via press release its results for the fiscal quarter ended June 30, 2026. A copy of Enanta's press release is hereby furnished to the Commission and incorporated by reference herein as Exhibit 99.1.2026-08-10SEC EDGAR 8-K 0001193125-26-342336 (text as filed, excerpt)2026-11-22 00:37 UTCReport an error
Employer name (as filed)Enanta Pharmaceuticals, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Total worker positions on certified LCAs12026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Top job titles (title, LCA count)Senior Clinical Data Manager (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Wage offered, annualized (n, min, median, max)median $161,803 (range $161,803-$161,803, 1 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Worksite statesMA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-22 00:37 UTCReport an error
Plan (pension, plan no. 001)ENANTA PHARMACEUTICALS, INC. 401(K) PROFIT SHARING PLAN & TRUST: 219 participants, assets $63,549,2762025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:37 UTCReport an error
Plan (welfare, plan no. 501)ENANTA HEALTH AND WELFARE BENEFITS PLAN: 124 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:37 UTCReport an error
Largest institutional holder #1 (13F as filed): Jupiter Topco LLC$53,252,1842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #2 (13F as filed): BlackRock, Inc.$47,304,0512026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #3 (13F as filed): FARALLON CAPITAL MANAGEMENT, L.L.C.$35,257,3852026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #4 (13F as filed): Deep Track Capital, LP$21,055,9552026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #5 (13F as filed): ADAR1 Capital Management, LLC$19,602,9562026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$17,667,5922026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #7 (13F as filed): Spruce Street Capital LP$15,873,6982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #8 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$14,747,5832026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$11,325,8422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error
Largest institutional holder #10 (13F as filed): MILLENNIUM MANAGEMENT LLC$9,389,0392026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:37 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.